Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
67.78
-1.53 (-2.21%)
At close: Feb 13, 2026, 4:00 PM EST
67.23
-0.55 (-0.81%)
After-hours: Feb 13, 2026, 6:31 PM EST
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $4.57 billion as of February 13, 2026. Its market cap has increased by 89.15% in one year.
Market Cap
4.57B
Enterprise Value
4.00B
1-Year Change
89.15%
Ranking
Category
Stock Price
$67.78
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $4.57B, an increase of 465.51%. That is a compound annual growth rate of 95.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.57B | -10.20% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 5.22B |
| Protagonist Therapeutics | 5.12B |
| Structure Therapeutics | 4.98B |
| Celcuity | 4.85B |
| Scholar Rock Holding | 4.76B |
| CRISPR Therapeutics AG | 4.66B |
| Crinetics Pharmaceuticals | 4.52B |
| Amicus Therapeutics | 4.50B |